Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Circulating MOTS-c is detectable in humans and declines with age, but no completed human trial of administered MOTS-c has read out
A licensed nurse will give you some paperwork to fill out to get your medical history
Some participants achieved weight loss of approximately 24% of body weight at 48 weeks approaching levels reported with some bariatric surgical procedures, though no direct head-to-head comparisons have been conducted and long-term durability beyond the trial period remains unknown
AOD9604 is classified under the Peptide Hormones and Related Substances category by WADA, making it a banned compound in all forms of competitive athletics. World AntiDoping Agency Disclaimer The content in this article is provided for educational and informational purposes only
